Serafin Andrew
SEC CIK 1821460 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | Chief STRATEGY Off | 2,600 | — | $2.29M | 6 | 2022-12-02 | 2026-01-24 |
Most active insiders at HRMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Budur Kumar | Chief MEDICAL Off | — | $3.11M |
| 2 | Kapadia Sandip | CFO | — | $1.80M |
| 3 | Dayno Jeffrey M. | Pres, CEO, Dir | — | $1.04M |
| 4 | Zaeske Adam H. | Chief COMMERCIAL Off | — | — |
| 5 | Serafin Andrew | Chief STRATEGY Off | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | M - OptEx | $0.00 | +5,100 | 2,600 | New | $0 |
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | F - Tax | $36.82 | -2,242 | 1,474 | -60% | -$82.6K |
| D | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | M - OptEx | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | F - Tax | $38.01 | -865 | 1,635 | -35% | -$32.9K |
| DM | 2022-12-05 | 2022-12-02 | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | S - Sale+OE | $60.13 | -38.0K | 920 | -98% | -$2.29M |
| D | 2022-12-05 | 2022-12-02 | HRMY | Harmony Biosciences Holdings, Inc. | Serafin Andrew | Chief STRATEGY Off | M - OptEx | $8.22 | +38.0K | 38.0K | New | +$312.4K |
Purchase Sale Sale after option exercise All abbreviations